AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11306831
Drug: Topical tacalcitol
RxNorm normalized name: tacalcitol Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tacalcitol
Trial: 9209899
Drug: Nafarelin 200
RxNorm normalized name: nafarelin 200 MCG/ACTUAT Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafarelin 200 micrograms plus Norethisterone 1.2 mg (Group C)
Trial: 8132186
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment for one year
Trial: 3191000
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil
Trial: 30597503
Drug: Adjusted dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjusted dose of enoxaparin according to anti-factor Xa levels
Trial: 21142609
Drug: 300 μg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 μg/day transdermal testosterone patch (TTP)
Trial: 14723338
Drug: Blend of
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blend of partially purified Yucca schidigera and Quillaja saponaria extracts (0.9 mg daily for 4 weeks)
Trial: 8732309
Drug: 600-1200 mg
RxNorm normalized name: pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 600-1200 mg of CX516
Trial: 25864194
Drug: Single-dose trandolapril
RxNorm normalized name: Trandolapril
DrugBank: Trandolapril (DB00519)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose trandolapril (1 mg, 2 mg, 4 mg)
Trial: 25864194
Drug: Multiple-dose trandolapril
RxNorm normalized name: Trandolapril
DrugBank: Trandolapril (DB00519)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose trandolapril (2 mg/day for 6 days)
Trial: 25864194
Drug: Single-dose trandolapril
RxNorm normalized name: Trandolapril
DrugBank: Trandolapril (DB00519)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose trandolapril
Trial: 25864194
Drug: Single and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single and multiple doses of trandolapril
Trial: 18333870
Drug: Maraviroc (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc (doses ranged from 3 mg b.i.d. to 600 mg q.d.)
Trial: 14575630
Drug: Southern Implant
RxNorm normalized name: Fluzone 2025 Southern Hemisphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Southern Implant System
Trial: 9493701
Drug: Barnidipine 10
RxNorm normalized name: barnidipine
DrugBank: Barnidipine (DB09227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine 10 mg
Trial: 11221289
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with enalapril (up to 10 mg once daily)
Trial: 1557929
Drug: 1.0 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 micrograms antigen per dose, abbreviated schedule (days 0, 7, 21)
Trial: 1557929
Drug: 1.0 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 micrograms antigen per dose, conventional schedule (days 0, 28, 300)
Trial: 1557929
Drug: 1.5 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 micrograms antigen per dose, conventional schedule (days 0, 28, 300)
Trial: 1557929
Drug: 2.0 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 micrograms antigen per dose, conventional schedule (days 0, 28, 300)
Trial: 1557929
Drug: 1.5 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 micrograms antigen per dose, abbreviated schedule (days 0, 7, 21)
Trial: 1557929
Drug: 2.0 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 micrograms antigen per dose, abbreviated schedule (days 0, 7, 21)
Trial: 4093346
Drug: Piperacillin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin (4 X 2 g for 48 h)
Trial: 19695387
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg (followed by 200 mg q12h)
Trial: 19695387
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 550 mg (followed by 550 mg q12h)
Trial: 19695387
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium 550 mg (study 2 only)
Trial: 16544756
Drug: Homeopathic drug
RxNorm normalized name: homeopathic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic drug 'Avia-more'
Trial: 14557430
Drug: Oral weekly
RxNorm normalized name: ELAGOLIX/ESTRADIOL/NORETHINDRONE CAP,ORAL WEEKLY PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral weekly ibandronate (20 mg)
Trial: 14557430
Drug: Both regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both regimens (weekly and daily ibandronate)
Trial: 9088782
Drug: Subcutaneous nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous nicotine injections (2 x 0.3 mg)
Trial: 9088782
Drug: Subcutaneous nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous nicotine injections (2 x 0.6 mg)
Trial: 9088782
Drug: Subcutaneous nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous nicotine (0.6 mg)
Trial: 1490435
Drug: Aztreonam, intramuscularly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aztreonam, intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days
Trial: 1490435
Drug: Chloramphenicol, orally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol, orally in a dose of 50 to 70 mg/kg body weight every 6 h for 12 days
Trial: 29943838
Drug: Antifungal agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antifungal agents (systemic and topical)
Trial: 28831618
Drug: Behavioral HIV
RxNorm normalized name: HIV Integrase Inhibitor
DrugBank: HIV Integrase Inhibitor (DB16114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral HIV prevention intervention integrating in-person and mobile phone delivered HIV risk reduction counseling, and daily, personalized text or voice messages.
Trial: 18838938
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (including saline)
Trial: 18838938
Drug: Inhaled bronchodilator
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled bronchodilator treatments
Trial: 3777409
Drug: Nalbuphine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 2.5 mg
Trial: 12618286
Drug: Nalbuphine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 2.5 mg + Naloxone 0.4 mg
Trial: 3777409
Drug: Nalbuphine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 5 mg
Trial: 15834273
Drug: Caffeine (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (median dose: 410 mg/day)
Trial: 15834273
Drug: Coffee (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee (median intake: 725 ml/day)
Trial: 7721409
Drug: Enalapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5 mg on each of 5 days preceding the study)
Trial: 7721409
Drug: Candoxatrilat (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatrilat (200 mg IV)
Trial: 6786952
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nutrient solution of hypertonic glucose and amino acids, 44.7 +/- 9.0 kcal/kg/day)
Trial: 31833718
Drug: 5-alpha reductase
RxNorm normalized name: 5-alpha reductase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-alpha reductase inhibitors (5-ARIs) for at least 12 months
Trial: 31833718
Drug: Untreated with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated with 5-alpha reductase inhibitors (5-ARIs)
Trial: 18762438
Drug: Prolonged-release oral
RxNorm normalized name: Niacin 1 g prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release oral oxycodone co-administered with naloxone (10 mg/day, 20 mg/day, 40 mg/day)
Trial: 18762438
Drug: Prolonged-release oral
RxNorm normalized name: Niacin 1 g prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release oral naloxone (20 mg/day and 40 mg/day)
Trial: 17525906
Drug: 1-hour infusion
RxNorm normalized name: coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT [Alprolix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-hour infusion of daunorubicin (DNR) at a dose of 36 mg/m²
Trial: 17525906
Drug: 24-hour infusion
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein, recombinant 0.24 MG/ML [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour infusion of daunorubicin (DNR) at a dose of 36 mg/m²
Trial: 17525906
Drug: 1-hour infusion
RxNorm normalized name: coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT [Alprolix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-hour infusion of daunorubicin (DNR)
Trial: 17525906
Drug: 24-hour infusion
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein, recombinant 0.24 MG/ML [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour infusion of daunorubicin (DNR)
Trial: 2866607
Drug: Acetylcysteine 200
RxNorm normalized name: acetylcysteine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcysteine 200 mg three times a day
Trial: 15107600
Drug: Levosimendan (LS)
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan (LS) 0.5 mg four times daily with felodipine (FD) 5 mg once daily
Trial: 15107600
Drug: Felodipine (FD)
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine (FD) 5 mg once daily
Trial: 8838439
Drug: Ethanol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.15 g kg-1)
Trial: 1595589
Drug: Chronic magnesium
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic magnesium administration (CMA) 4.5 g/d for 4 weeks
Trial: 31477748
Drug: Preservative-free diquafosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free diquafosol administered 6 times daily after surgery
Trial: 31477748
Drug: Preservative-containing diquafosol
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-containing diquafosol administered 6 times daily after surgery
Trial: 31477748
Drug: Preservative-free hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free hyaluronate administered 6 times daily after surgery
Trial: 29504880
Drug: Acetaminophen/Codeine (Tylex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen/Codeine (Tylex 30 mg: acetaminophen 500 mg/codeine 30 mg)
Trial: 29504880
Drug: Acetaminophen/Codeine (Tylex)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen/Codeine (Tylex)
Trial: 22471392
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg for 4 weeks
Trial: 21883698
Drug: Capsaicin (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (0.75 mg)
Trial: 9011455
Drug: Somatostatin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (250 microg bolus injection)
Trial: 3904436
Drug: Buffered aspirin
RxNorm normalized name: Buffered Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buffered aspirin
Trial: 25706772
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa (NS) 2g daily for one year
Trial: 20026488
Drug: Hyaluronan-based heparin-bonded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronan-based heparin-bonded circuits (Vision HFO-GBS, Gish, CA, USA)
Trial: 10435208
Drug: Naloxone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 2.0 mg/kg
Trial: 8627976
Drug: Intracoronary nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary nicorandil (0.25, 0.50, 1.0 mg)
Trial: 8627976
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN; 1.0 mg)
Trial: 6793182
Drug: Chlorpropamide (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpropamide (two weeks treatment)
Trial: 6793182
Drug: Chlorpropamide (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpropamide (single tablet)
Trial: 19811373
Drug: Augmentation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentation therapy with exogenous α1-antitrypsin (α1-AT)
Trial: 2806927
Drug: control experiments
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL GEL [Quality Metalcraft Experi-Metal Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control experiments without levodopa administration
Trial: 335382
Drug: Nerisone cream
RxNorm normalized name: Nerisone
DrugBank: Difluocortolone (DB09095)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerisone cream (diflucortolone valerate 0.1%)
Trial: 335382
Drug: Fluocinolone-acetonide ointments
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone-acetonide ointments
Trial: 23867047
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual drug education)
Trial: 17485709
Drug: Peritumoral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritumoral injection of blue dye
Trial: 17485709
Drug: Peritumoral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritumoral injection by probe
Trial: 17485709
Drug: Periareolar injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periareolar injection
Trial: 17485709
Drug: Peritumoral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritumoral injection
Trial: 7985162
Drug: Capoten treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capoten treatment according to the chronosensitivity-adjusted regimen
Trial: 9620514
Drug: Alfentanil 0.5
RxNorm normalized name: alfentanil 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 0.5 mg
Trial: 30911271
Drug: Single-dose dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose dexmedetomidine (0.5 μg/kg) combined with low-dose remifentanil infusion (1 ng/mL)
Trial: 30911271
Drug: High-dose remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose remifentanil infusion (2 ng/mL)
Trial: 21178605
Drug: Preemptive low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preemptive low-dose epidural ketamine (0.12% levobupivacaine, 2 μg/mL of fentanyl, 0.2 mg/mL ketamine, total volume of 500 mL)
Trial: 18155054
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (lidocaine 2.5% and prilocaine 2.5%), approximately 5 g
Trial: 18155054
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (neomycin ointment, approximately 5 g)
Trial: 22516310
Drug: Celecoxib (200mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200mg twice daily)
Trial: 11137591
Drug: Antibiotics prescribed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics prescribed at discharge (amoxicillin clavulanate in 41%, amoxicillin in 15%, cefuroxime axetil in 11%, cefaclor 6%, azithromycin 5%)
Trial: 11137591
Drug: First choice
RxNorm normalized name: First Choice Strip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First choice antibiotics
Trial: 11137591
Drug: Alternate use
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate use antibiotics
Trial: 11137591
Drug: Inadequate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inadequate treatment
Trial: 11137591
Drug: Variability in
RxNorm normalized name: Ferric carbonate, ferric hydroxide, ferrous hydroxide (variable mixture)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Variability in antibiotic prescription
Trial: 9205758
Drug: Ebrotidine single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebrotidine single doses (25 to 1600 mg)
Trial: 9205758
Drug: Ebrotidine multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebrotidine multiple doses (400 to 800 mg every 12 hours for 12 days)
Trial: 9205758
Drug: Ebrotidine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebrotidine (single and multiple doses)
Trial: 3076709
Drug: Mefloquine-sulfadoxine-pyrimethamine (MSP)
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine-sulfadoxine-pyrimethamine (MSP) at doses of 1, 1.5, or 2 standard MSP tablets (equivalent to 7.1-12.5 mg/kg mefloquine, 14.3-25.0 mg/kg sulfadoxine, 0.7-1.3 mg/kg pyrimethamine)
Trial: 25794622
Drug: TSHH (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TSHH (7.5 μg tiotropium/25 μg salmeterol, once daily)
Trial: 25794622
Drug: TioHH (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TioHH (18 μg tiotropium, once daily)
Trial: 25794622
Drug: SalD (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SalD (50 μg salmeterol, twice daily)
Trial: 25794622
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of TioHH (qd) plus SalD (bid)
Trial: 23945570
Drug: Intramuscular gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular gentamicin once daily and oral amoxicillin twice daily for 7 days
Trial: 23945570
Drug: Intramuscular penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular penicillin and gentamicin once daily for 2 days followed by oral amoxicillin twice daily for additional 5 days
Trial: 23945570
Drug: Intramuscular procaine-benzyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular procaine-benzyl penicillin and gentamicin given once daily for 7 days
Trial: 14504951
Drug: Subcutaneous adipose
RxNorm normalized name: human adipose preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous adipose tissue layers (SAT-layers) measured by LIPOMETER at various body sites.
Trial: 9095609
Drug: PGE1 infusion
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 infusion at 0.02 microgram.kg‐1.min‐1 before induction of anesthesia
Trial: 8240151
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg daily, titrated to 40 mg daily
Trial: 8240151
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg daily, titrated to 40 mg daily
Trial: 24729041
Drug: Everolimus (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (4.5 mg/m²/day)
Trial: 22951490
Drug: Rilpivirine (RPV)
RxNorm normalized name: Rilpivirine
DrugBank: Rilpivirine (DB08864)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rilpivirine (RPV) 25 mg once daily
Trial: 21049089
Drug: Haloperidol 2-20
RxNorm normalized name: haloperidol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 2-20 mg/day
Trial: 21049089
Drug: Risperidone 2-10
RxNorm normalized name: risperidone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 2-10 mg/day
Trial: 21049089
Drug: Ziprasidone 80-160
RxNorm normalized name: ziprasidone 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone 80-160 mg/day
Trial: 18284439
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment with venlafaxine for 2 years
Trial: 18284439
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment with venlafaxine
Trial: 1806734
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg of ASA
Trial: 6859372
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of seminal plasma antibodies (titers up to 16)
Trial: 6859372
Drug: Perioperative steroids
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative steroids (randomized controlled trial)
Trial: 27189190
Drug: Podiatry treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Podiatry treatment